Pfizer Boasts Strong Oncology Portfolio: Can it Sustain Growth?
The addition of Seagen in 2023 also strengthened its position in oncology by adding four ADCs — Adcetris, Padcev, Tukysa and Tivdak. The acquired Seagen products contributed meaningfully to Pfizer's revenues in 2024 and in the first quarter of 2025. Seagen also has some next-generation ADC candidates in its pipeline.
Pfizer's oncology revenues grew 7% on an operational basis in the first quarter of 2025, driven by drugs like Xtandi, Lorbrena, the Braftovi-Mektovi combination and Padcev.
Pfizer has also ventured into the oncology biosimilars space and markets six biosimilars for cancer. Pfizer has also advanced its oncology clinical pipeline with several candidates entering late-stage development, like sasanlimab, vepdegestrant and sigvotatug vedotin. In May, Pfizer inked an exclusive licensing deal with China's 3SBio for the latter's dual PD-1 and VEGF inhibitor, which will strengthen its oncology pipeline.
Pfizer is also working on expanding the labels of approved oncology products like Padcev and Adcetris, among others.
With all the above developments, Pfizer's future in cancer treatment looks promising.
Competition in the Oncology Space
Other large players in the oncology space are AstraZeneca AZN, Merck MRK and Bristol-Myers BMY.
For AstraZeneca, oncology sales now comprise around 41% of total revenues. Sales in its oncology segment rose 13% in the first quarter of 2025. AstraZeneca's strong oncology performance was driven by medicines such as Tagrisso, Lynparza, Imfinzi, Calquence and Enhertu (in partnership with Daiichi Sankyo).
Merck's key oncology medicines are PD-LI inhibitor, Keytruda and PARP inhibitor, Lynparza, which it markets in partnership with AstraZeneca. Keytruda, approved for several types of cancer, alone accounts for around 50% of Merck's pharmaceutical sales.
Bristol-Myers' key cancer drug is PD-LI inhibitor, Opdivo, which accounts for around 20% of its total revenues.
PFE's Price Performance, Valuation and Estimates
Pfizer's stock has declined 6.8% so far this year against an increase of 0.2% for the industry.
Image Source: Zacks Investment Research
From a valuation standpoint, Pfizer appears attractive relative to the industry and is trading below its 5-year mean. Going by the price/earnings ratio, the company's shares currently trade at 7.77 forward earnings, lower than 15.05 for the industry and the stock's 5-year mean of 10.90.
The Zacks Consensus Estimate for 2025 earnings has risen from $2.98 per share to $3.06 per share, while that for 2026 has gone up from $3.00 to $3.09 per share over the past 60 days.
Pfizer has a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
Only $1 to See All Zacks' Buys and Sells
We're not kidding.
Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.
Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators, and more, that closed 256 positions with double- and triple-digit gains in 2024 alone.
See Stocks Now >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
AstraZeneca PLC (AZN): Free Stock Analysis Report
Bristol Myers Squibb Company (BMY): Free Stock Analysis Report
Pfizer Inc. (PFE): Free Stock Analysis Report
Merck & Co., Inc. (MRK): Free Stock Analysis Report
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CBC
an hour ago
- CBC
My baby nearly didn't survive her birth. Her presence has made me a grateful mom
This First Person article is the experience of Lauren Helstrom, who lives in Saskatoon with her daughter Evee. For more information about CBC's First Person stories, please see the FAQ. Right from the moment of her delivery, my daughter's life hung by a thread. I'd gone into labour 17 weeks before my due date, and something in my bones screamed danger. After getting admitted at the hospital, I was rushed onto a stretcher and wheeled through double doors, past people too afraid to meet my gaze. It felt like the room itself was holding its breath. I was supposed to say goodbye. A labour and delivery nurse kneeled beside me, gripped my hand and whispered, "I'm not leaving you." I didn't know how badly I needed those words until they reached me. Motherhood didn't begin the way I dreamed. But strangers in masks and gowns gave me the chance to be the mother I dreamed I could be. My daughter, Evee, was born at 23 weeks and four days gestation, weighing 561 grams — just the size of a bag of candy. She emerged still wrapped in her amniotic sac — skin like wet rose petals, lungs too tiny to rise and fall. She was silent. No heartbeat. Not breathing. But the neonatal intensive care unit (NICU) team was there and ready, not to mourn, but to fight. A resident stepped in to resuscitate her. I will never forget his face — the tears in his eyes as he fought for her life with both hands. They brought her back. They saved her. They saved us both. A ghost of a mother The NICU was like another planet. Foreign. Unforgiving. Sacred. I wasn't handed my baby. I wasn't even allowed to touch her. She lay inside a glass box, her chest flickering with effort, tangled in wires and tubes. Machines surrounded her — blinking, hissing, screaming a language I didn't understand. I sat at her bedside, afraid to breathe too loud and overwhelmed by alarms that wouldn't stop. They pierced my eardrums and stabbed my heart. The first time I sang You Are My Sunshine, I didn't make it past the line, "Please don't take my sunshine away." I wept into my hands. Was I a mother? I couldn't cradle my baby or feed her. I needed permission just to place my fingertip on her paper-thin skin. I felt like a ghost of a mother. Invisible. Useless. Failing. I was haunted by the feeling: "You're saying goodbye." Evee spent 130 days in the NICU. She battled retinopathy of prematurity, chronic lung disease, seizures, an open duct in her heart and the worst yet — a grade 4 brain bleed and hydrocephalus. Through it all, the NICU staff were the hands that held me when I collapsed. And yet, within that grief, there was devotion. If you're a parent - you'll remember what it was like to be in a hospital delivery room. That memory is still fresh for Lauren Helstrom, whose daughter was born 17 weeks prematurely and spent the first months of her life at the neonatal intensive care unit in Saskatoon. Lauren has written a First Person piece for CBC on that experience, and shares her insights with host Shauna Powers. I changed her micro-sized diapers with trembling hands. I started to feel like her mother not in dramatic moments, but in small sacred ones — when she grasped my finger, or when a nurse said, "She knows your voice." When another NICU parent passed me in the hallway and gave a nod like we shared something unspoken. We were part of a club no one wanted to join. Even after we came home, we faced a new chapter filled with medical complexity, with several continued check-ups that continue for Evee today. And the shadows continued to visit. Post-traumatic stress after the NICU is not rare. It is real. It is silent. And it can destroy you if you carry it alone. The wounds don't close just because you've been discharged. But slowly, we've emerged from that dark time in NICU. My daughter didn't walk or talk until after the age of two. But once she started — she ran, she talked, she laughed. Now, at age three, Evee is vibrant and full of life. She dances barefoot in the kitchen and sings with her whole chest. She calls me "Mommy" like it's the most natural word in the world. I became a mother in a room where I once felt I had to say goodbye. I became a mother beside ventilators, signing forms, praying silently. I became a mother when I learned to hold hope and fear in the same breath. I became a mother the moment I refused to stop asking for help. I became a mother when I stayed by her side while others left the room. I became a mother when I looked at her — impossibly small, impossibly alive — and whispered: "Stay with me, my girl." And she did.
Globe and Mail
2 hours ago
- Globe and Mail
Ottawa is quietly working on launching a new entity it hopes will be key to housing affordability
Prime Minister Mark Carney's government has been quiet since the federal election about the housing crisis, the same issue that contributed to the Liberals' fading popularity under their previous leader. Behind the scenes, however, housing stakeholders are fielding a flurry of calls from government officials seeking their advice on the creation of Build Canada Homes, a new federal entity that Mr. Carney has said will get the government back in the business of homebuilding. His ambitions, announced during his campaign, were big: act as a developer to build affordable housing, spur innovation in the housing sector and offer low-cost financing to affordable-housing builders. However, trade turmoil has quickly overshadowed housing affordability in the political arena, creating a void of information on how the federal government plans to get more homes built. Renée LeBlanc Proctor, a spokesperson for Housing Minister Gregor Robertson, said in a statement that the government was on track to launch the initiative this fall and stakeholders would learn more soon. But questions still linger about how the new entity will function, and what its creation will mean for existing programs. Meanwhile, some leaders in the housing policy and advocacy spaces are worried that if the government doesn't move quickly to spur more supply, the economic slowdown caused by U.S. tariffs will set plans further behind. Mr. Carney promised the initiative would be a 'lean, mission-driven organization' focused on building affordable housing by leveraging public lands and partnering with the private sector. He pitched it as a central piece of the government's plan to double the rate of homebuilding in the country. Opinion: Ottawa must resist the temptation to fiddle with CMHC amid housing market slump Raymond Sullivan, executive director of the Canadian Housing and Renewal Association, an organization that represents the social and non-profit housing sector, said he's encouraged to see affordable housing at the heart of Build Canada Homes' mission. But given how long it can take to set up a new bureaucracy, Mr. Sullivan said the government should roll out elements of Build Canada Homes as they become ready, rather than wait for the entire organization to be set up. 'We're not going to have a cake that's fully baked and ready to launch in the fall. So let's focus on the pieces that are already available to us,' he said. University of Toronto senior housing researcher Carolyn Whitzman said there are two versions of the initiative that are being discussed in policy circles: one that is limited in scope and focused primarily on partnering with developers to build affordable housing on public land, and one that also has a larger mandate encompassing financing and innovation programs. Figuring out what exactly Build Canada Homes will be responsible for and how it will distinguish itself from organizations such as the Canada Mortgage and Housing Corporation appear to be some of the details Ottawa is trying to hammer out, according to stakeholders consulted by the government. Mr. Sullivan said Ottawa should ensure social-housing projects in the pipeline are not affected by the organization's creation. 'We don't want to see any kind of interruption. We need to know that the government is there as a partner with us, not sitting back for a year building a new structure, but ready to work on things that are ready,' he said. Real estate is not a financial slam dunk, Canadians are learning the hard way Some housing experts and stakeholders are skeptical that Build Canada Homes will be a sufficient solution to the housing shortage. The government has had mixed success with its housing initiatives in the past — such as the slow progress it's made on converting unused office space into affordable housing recently flagged by the Auditor-General — and a new organization will likely take time to begin delivering results. 'They've talked about partnering with industry to actually build the units, which will be important, because governments around the world have proven that they can't properly get into the actual construction game,' said Kevin Lee, CEO of the Canadian Home Builders' Association. Mr. Lee said building affordable housing on public lands also won't be enough to get the government to its goal of 500,000 housing starts a year. (The seasonally adjusted annual rate of housing starts was 283,734 units in June.) Meanwhile, the private and social-housing sectors are impatient for clarity on other policy fronts, including the promised GST rebate for first-time homebuyers. Mr. Lee said the delay is affecting demand at a time when the economy is already slowing down the housing market. 'Having something like that that was promised not get turned into official policy has really thrown another wrench into the system,' said Mr. Lee. Proposed GST rebate for first-time homebuyers could offer average relief of $27,000, PBO says Finance Minister François-Philippe Champagne introduced legislation in late May to provide the GST rebates. But unlike the government's 'One Canadian Economy' legislation, which was rushed through the House of Commons and Senate during the four-week sitting, the bill on GST rebates must wait for Parliament to return in the fall. The government's prioritization of fast-tracking approvals for major projects and managing trade tensions with the U.S. reflects a shift in the public's priorities, as well. Polling by Abacus Data shows U.S. President Donald Trump is the second-most important issue to Canadians, with housing and the economy nearly tied for third. (The rising cost of living – which includes housing costs – was the No. 1 issue.) Mike Moffatt, founding director of the University of Ottawa's Missing Middle Initiative, said the shift in priorities is understandable, though he warned housing could become of greater importance again. 'The government would be doing itself favours if they do the legwork now, because if it becomes a big concern, or the primary concern for Canadians, again, it might be too late to really address that,' Mr. Moffatt said. The trade war with the United States also has repercussions for the housing market, which won't make the government's job of spurring homebuilding any easier. RBC assistant chief economist Robert Hogue said the housing market is slowing down in part as 'payback for an exceptionally strong period' after the onset of the COVID-19 pandemic. 'However, the trade war kind of put a damper on things and really affected confidence in most of Canada, and that's when we saw, through the winter and spring, a lot of potential home buyers saying, 'might as well sit it out,'' he said. These three housing markets are bucking national trends, and Trump is one reason why 'The challenge is to get more demand for new construction at a time when building costs have gone up and and you've got now more inventory in the existing home market, in many places around Canada.' Mr. Moffatt said as the government works on setting up the organization, it needs to roll out policies that will have a more immediate effect on the housing market. For example, the government could expand its proposed GST rebate so that all homebuyers of a primary residence are eligible, he said. Ontario Premier Doug Ford said in the spring his government would match the tax break if it were extended to all homebuyers. Prof. Whitzman said social-housing builders also are seeking information on a number of programs, including the affordable housing fund, which provided capital for the repair of existing affordable and community housing. That fund recently ran out of money, leaving its future in limbo. 'I'm not saying Build Canada Homes is a bad idea,' she said. 'But there's stuff that could be happening tomorrow and there's stuff that should be happening tomorrow.'
CBC
3 hours ago
- CBC
What is swimmer's itch? And how can you treat it?
For many, it's not summer until you've taken a dip in one of B.C.'s glistening lakes, a welcome reprieve from those hot July days. But sometimes, you end up with something not so welcome: itchy red bumps on your skin. Some call it swimmer's itch, some call it duck itch, and for others, it's simply the itch. But what is it, exactly? University of Northern British Columbia zoologist Dezene Huber said that itch — whatever you call it — is caused by a parasitic flatworm. "It's really quite tiny," he told CBC's Daybreak North guest host Bill Fee. "You're not able to really see it very well with your naked eye." That worm begins as an egg in the water, Huber said, and when it hatches, the little larvae swim using little hairs on the sides of their bodies in search of a snail. Once they get into the snail, they reproduce asexually in "vast numbers." From there, the new larvae leave the snail, in search of something larger — any sort of water bird, but usually a duck, Huber said. Once they find a duck, they burrow into the bird's feet and get into its circulatory system en route to its gut. That's where they lay the eggs that are then returned to the water when the duck poops. You may notice humans aren't involved in that life cycle at all. But humans, like ducks, are warm in the water, so sometimes, those little parasites mistake people for ducks. "They're really well adapted to survive in a duck, but they're not well adapted to survive in a human, so as soon as they burrow into the skin of a human, they die just underneath the skin of the human and that causes an allergic reaction," Huber said. "It's basically parasites making mistakes in a fairly complex life cycle." Those itchy red bumps you get are an immune response as your body rejects a parasite trying to get inside you, Huber said. Treatment While these parasites aren't causing long-term harm to humans, that itch can be pretty uncomfortable. According to the province, scratching those bumps can lead to pain and even infection. Fort St. James, B.C., pharmacist Ankur Pipaliya said the best tip for avoiding the itch is to avoid swimming in areas known to be a problem for swimmer's itch.. But, if you do, he said, towel dry or shower immediately after you get out of the water. Showers should be with cold water, Pipaliya said. And then, he said, apply moisturizer. "Dry skin, it promotes that allergic reaction. So if your skin is moist, it kind of helps you from having any irritations." If it's too late and you've already got red, itchy bumps from swimming in the lake, Pipaliya said he usually suggests mild corticosteroid creams to reduce discomfort, along with cold showers and cold compresses on the bumps. He said Epsom salts and baking soda also help, as well as over-the-counter allergy medications like Benadryl. The province also suggests calamine lotion and colloidal oatmeal baths for relief from swimmer's itch. It said symptoms can develop within 12 hours after infection, and can last anywhere from two days to two weeks.
